DK2403512T3 - Sammensætninger af polymer myrcen - Google Patents

Sammensætninger af polymer myrcen Download PDF

Info

Publication number
DK2403512T3
DK2403512T3 DK10710912.6T DK10710912T DK2403512T3 DK 2403512 T3 DK2403512 T3 DK 2403512T3 DK 10710912 T DK10710912 T DK 10710912T DK 2403512 T3 DK2403512 T3 DK 2403512T3
Authority
DK
Denmark
Prior art keywords
myrc
compositions
polymer
polymer myrc
Prior art date
Application number
DK10710912.6T
Other languages
English (en)
Inventor
Shimon Amselem
Zadik Hazan
Original Assignee
Regenera Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regenera Pharma Ltd filed Critical Regenera Pharma Ltd
Application granted granted Critical
Publication of DK2403512T3 publication Critical patent/DK2403512T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/22—Anacardiaceae (Sumac family), e.g. smoketree, sumac or poison oak
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
DK10710912.6T 2009-03-04 2010-03-04 Sammensætninger af polymer myrcen DK2403512T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15721609P 2009-03-04 2009-03-04
PCT/IL2010/000184 WO2010100651A2 (en) 2009-03-04 2010-03-04 Compositions of polymeric myrcene

Publications (1)

Publication Number Publication Date
DK2403512T3 true DK2403512T3 (da) 2019-07-22

Family

ID=42536397

Family Applications (1)

Application Number Title Priority Date Filing Date
DK10710912.6T DK2403512T3 (da) 2009-03-04 2010-03-04 Sammensætninger af polymer myrcen

Country Status (15)

Country Link
US (4) US8722105B2 (da)
EP (2) EP2403512B1 (da)
CN (2) CN102413834B (da)
AU (1) AU2010220057C1 (da)
BR (1) BRPI1013222B8 (da)
CA (1) CA2754565C (da)
DK (1) DK2403512T3 (da)
EA (2) EA201492273A1 (da)
ES (1) ES2739033T3 (da)
HK (1) HK1218710A1 (da)
HU (1) HUE045444T2 (da)
IL (2) IL214923A (da)
PL (1) PL2403512T3 (da)
TR (1) TR201911270T4 (da)
WO (1) WO2010100651A2 (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA201492259A1 (ru) 2009-03-04 2015-04-30 Редженера Фарма Лтд. Терапевтические применения фракций мастиковой смолы
BRPI1013222B8 (pt) 2009-03-04 2021-05-25 Regenera Pharma Ltd composição que consiste em uma fração isolada de goma mastique obtida de pistacia lentiscus l.
CA2779025A1 (en) * 2009-10-28 2011-05-05 Regenera Pharma Ltd. Therapeutic uses of oligomeric and polymeric monoterpenes
CN106924266A (zh) 2010-09-07 2017-07-07 瑞吉纳拉制药公司 包含乳香的酸性提取物的组合物
US8979797B2 (en) * 2010-12-16 2015-03-17 Ams Research Corporation High pressure delivery system and method for treating pelvic disorder using large molecule therapeutics
US10307292B2 (en) 2011-07-18 2019-06-04 Mor Research Applications Ltd Device for adjusting the intraocular pressure
CN102526163A (zh) * 2011-12-27 2012-07-04 浙江景岳堂药业有限公司 一种用于风痛灵中乳香和没药的提取方法
US20150246087A1 (en) * 2012-06-11 2015-09-03 Regenera Pharma Ltd. Extracts and therapeutic uses thereof
US9458362B2 (en) 2014-04-02 2016-10-04 Kraton Polymers U.S. Llc Adhesive compositions containing a block copolymer with polymyrcene
US10053603B2 (en) 2014-04-02 2018-08-21 Kraton Polymers U.S. Llc Block copolymers containing a copolymer myrcene block
IL237621A0 (en) 2015-03-08 2015-06-30 Regenera Pharma Ltd Use of isolated fractions of the gum goddess to treat optic neuropathy
CA2999820A1 (en) 2015-09-24 2017-03-30 Regenera Pharma Ltd. Compositions comprising triterpenoids
CN108289863B (zh) 2015-09-24 2021-03-16 瑞吉纳拉制药公司 包含三萜类的组合物
US10548917B2 (en) * 2016-05-23 2020-02-04 Kaeco Group Inc. Supplement for the prevention and treatment of gastrointestinal distress in horses and other species
US11439676B2 (en) 2018-10-16 2022-09-13 Kaeco Group, Inc. Method for prevention or treating gastrointestinal distress in humans using mastic gum compositions
CN109922798A (zh) * 2016-09-08 2019-06-21 瑞吉纳拉制药公司 包括乳香胶的酸性提取物的组合物及其用于治疗视神经病变的用途
US11207333B2 (en) 2016-09-08 2021-12-28 Regenera Pharma Ltd. Compositions comprising triterpenoids and uses thereof for treating optic neuropathy
IT201700016726A1 (it) 2017-02-15 2018-08-15 Phytoitalia Srl Frazioni arricchite in terpeni esenti da politerpeni estratte dal mastice di chios, dispositivi cosmetici, nutraceutici e medici, e composizioni farmaceutiche che le contengono
WO2019170239A1 (en) 2018-03-08 2019-09-12 Phytoitalia Srl Terpene enriched fractions free from polyterpenes extracted from chios mastic gum and cosmetic, nutraceutical, medical devices and pharmaceutical compositions containing them
US20210393724A1 (en) * 2018-11-01 2021-12-23 Yeditepe Universitesi Medicine for treatment of psoriasis and production method thereof

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4374957A (en) 1981-10-29 1983-02-22 Michigan Molecular Institute Triblock polymers of a monovinyl aromatic compound and myrcene
US4564718A (en) 1984-08-14 1986-01-14 The University Of Manchester Institute Of Science And Technology Functionally terminated polymers from terpene monomers and their applications
US4713243A (en) 1986-06-16 1987-12-15 Johnson & Johnson Products, Inc. Bioadhesive extruded film for intra-oral drug delivery and process
JPS63179908A (ja) * 1987-01-22 1988-07-23 Japan Synthetic Rubber Co Ltd ミルセン重合体およびその製造方法
DE3820218A1 (de) 1988-06-14 1989-12-28 Osama L M Dr Med Dr Rer N Omer Phytotherapeutikum zur behandlung von depressivem syndrom
US8178516B2 (en) 1992-06-30 2012-05-15 Sylvan Labs, LLC Compositions and method for treatment of chronic inflammatory diseases
US5506406A (en) 1993-05-17 1996-04-09 Atomic Energy Corporation Of South Africa Ltd. Method and apparatus for determining the concentration of a heavy element in a rock face
US5759569A (en) 1995-01-10 1998-06-02 The Procter & Gamble Company Biodegradable articles made from certain trans-polymers and blends thereof with other biodegradable components
US5714007A (en) 1995-06-06 1998-02-03 David Sarnoff Research Center, Inc. Apparatus for electrostatically depositing a medicament powder upon predefined regions of a substrate
GR950100243A (el) 1995-06-28 1997-02-28 �. �����- �. ����� �.�.�. Χρησιμοποιηση της φυσικης μαστιχας χιου η του εξαγομενου εξ'αυτης φυσικου μαστιχελαιου η συνθετικων παραγωγων του για την παρασεκυη οδοντοκρεμας, οδοντικου διαλυματος, αποσμητικου στοματος, αντιηλιακων, προιοντων μαλλιων, καθως και καλλυντικων προιοντων.
JPH10130254A (ja) * 1996-11-01 1998-05-19 Jumoku Seiri Kinousei Butsushitsu Gijutsu Kenkyu Kumiai ジヒドロクマリン系化合物およびエストロゲン作用剤
DE19646392A1 (de) 1996-11-11 1998-05-14 Lohmann Therapie Syst Lts Zubereitung zur Anwendung in der Mundhöhle mit einer an der Schleimhaut haftklebenden, Pharmazeutika oder Kosmetika zur dosierten Abgabe enthaltenden Schicht
GR1003541B (el) 1999-05-11 2001-03-07 Αντιμικροβιακη και αντιμυκητιακη δραση του εξαγομενου απο τα κλαδια, φυλλα και καρπο της μαστιχας χιου -pistacia lentiscus var chia-, μαστιχελαιου, για χρηση σε καλλυντικες, φαρμακευτικες και παραφαρμακευτικεσς εφαρμογες καθως και στην παραγωγη οδοντοτσι
GR1003550B (el) 1999-09-22 2001-03-13 Σταθερο παρασκευασμα ισοεξυλοναφθαζαρινων με πεντα- και τετρα-κυκλικα τριτερπενια, συστατικα φυτικων ελαιορητινων και κομμεων
US6623728B2 (en) 2000-06-30 2003-09-23 Unilever Home & Personal Care Usa Division Of Conopco, Inc. Cosmetic skin care compositions and containing gum mastic
US7056491B2 (en) 2000-11-08 2006-06-06 Wisconsin Alumni Research Foundation Monoterpenes and sesquiterpenes as chemotherapeutic and radiation sensitizers and immunomodulators
GR1003868B (el) * 2001-02-06 2002-04-19 Lavipharm S.A. Αξιολογηση των επουλωτικων, αντιοξειδωτικων και κυτταροστατικων ιδιοτητων της μαστιχας και των συστατικων της, και οι εφαρμογες τους
EP1361863A2 (en) 2001-02-13 2003-11-19 Yissum Research Development Company Of The Hebrew University Of Jerusalem Carotenoid-loaded liposomes
US6534548B1 (en) 2001-10-02 2003-03-18 Kimberly-Clark Worldwide, Inc. Isoprenoid compositions for the inhibition of exoprotein production from gram positive bacteria
ATE441423T1 (de) 2002-05-01 2009-09-15 Lavipharm Sa Verwendung von mastix und dessen ätherischen ílen zur verhinderung oder bekämpfung von mikrobieller infektionen
JP2004083443A (ja) 2002-08-23 2004-03-18 Hideji Watanabe マスティックを用いた歯周病予防・治療用組成物及び歯周病予防・治療方法
JP4426527B2 (ja) 2002-12-20 2010-03-03 エクソンモービル・ケミカル・パテンツ・インク 重合プロセス
JP4441487B2 (ja) 2002-12-20 2010-03-31 エクソンモービル・ケミカル・パテンツ・インク 重合プロセス
US20050074509A1 (en) 2003-10-02 2005-04-07 Data Medica Padova S.P.A. Cancer treatment using natural plant products or essential oils extracted from some pistacia species or components
WO2005053812A1 (en) 2003-12-08 2005-06-16 Xylon Biotechnologies Ltd. Plant materials extraction method
DE602005024773D1 (de) 2004-03-04 2010-12-30 Riken Wako Isotaktisches 3,4-isopren-polymer
WO2005112967A2 (en) 2004-05-19 2005-12-01 Balfour Marketing Corp. Anticancer activity of chios mastic gum
US20070292445A1 (en) 2004-07-06 2007-12-20 Transpharma Medical Ltd. Delivery system for transdermal immunization
CA2574898C (en) 2004-07-23 2011-12-20 Tsung-Chung Lin Immune modulation and anti-allergy activities of zingiber zerumbet
NZ555219A (en) 2004-11-13 2011-03-31 Metaproteomics Llc Compositions exhibiting inhibition of cyclooxygenase-2
US20070036873A1 (en) 2005-07-27 2007-02-15 Shibnath Ghosal Method of treatment or management of stress
US20070148187A1 (en) 2005-12-27 2007-06-28 Intact Enterprises, Inc. Mastic gum composition for use as a dietary supplement in humans and animals
AR060847A1 (es) 2007-05-03 2008-07-16 Spannagel Lucia Antonia Formulacion a base de calendula, aloe y centella.
EA201492259A1 (ru) 2009-03-04 2015-04-30 Редженера Фарма Лтд. Терапевтические применения фракций мастиковой смолы
BRPI1013222B8 (pt) 2009-03-04 2021-05-25 Regenera Pharma Ltd composição que consiste em uma fração isolada de goma mastique obtida de pistacia lentiscus l.

Also Published As

Publication number Publication date
CA2754565C (en) 2020-12-29
CN102413834A (zh) 2012-04-11
EA201492273A1 (ru) 2015-04-30
CN102413834B (zh) 2016-11-09
IL248056A0 (en) 2016-11-30
US20140294928A1 (en) 2014-10-02
WO2010100651A4 (en) 2010-12-23
EP2403512A2 (en) 2012-01-11
US8722105B2 (en) 2014-05-13
AU2010220057B2 (en) 2015-04-02
EP3578191A1 (en) 2019-12-11
WO2010100651A3 (en) 2010-10-28
WO2010100651A2 (en) 2010-09-10
US20120039992A1 (en) 2012-02-16
US10806763B2 (en) 2020-10-20
CN105147759A (zh) 2015-12-16
US20170252387A1 (en) 2017-09-07
US20190255132A1 (en) 2019-08-22
AU2010220057A1 (en) 2011-10-13
IL248056B (en) 2019-07-31
HK1218710A1 (zh) 2017-03-10
CA2754565A1 (en) 2010-09-10
BRPI1013222B8 (pt) 2021-05-25
US9655938B2 (en) 2017-05-23
IL214923A0 (en) 2011-11-30
EA021833B1 (ru) 2015-09-30
HUE045444T2 (hu) 2019-12-30
ES2739033T3 (es) 2020-01-28
BRPI1013222A2 (pt) 2017-09-26
EA201190170A1 (ru) 2013-01-30
IL214923A (en) 2016-10-31
BRPI1013222B1 (pt) 2021-03-16
EP2403512B1 (en) 2019-05-15
PL2403512T3 (pl) 2019-10-31
TR201911270T4 (tr) 2019-08-21
AU2010220057C1 (en) 2015-10-29
US10307449B2 (en) 2019-06-04

Similar Documents

Publication Publication Date Title
DK2403512T3 (da) Sammensætninger af polymer myrcen
DK3078664T3 (da) Antiparasitiske dihydroazol-sammensætninger
BR112012005237A2 (pt) utilização de composições ternárias
SMT201600307B (it) Composizione liposomiale
UY33161A (es) Composiciones plaguicidas
DOP2011000396A (es) Composiciones novedosas
DK2498756T3 (da) Tabletformuleringer af neratinibmaleat
DK2640893T4 (da) Sammensætninger
BRPI1013588A2 (pt) composição
IT1400743B1 (it) Composizioni polimeriche
DK2633006T3 (da) Fremstilling af fornybart bio-destillat
DK2358714T3 (da) Alkylcyclohexylethere af dihydrotetraazabenzoazulener
BRPI1015474A2 (pt) composição
DK2459129T3 (da) Forbedringer af karstøtteanordninger
BRPI1010690A2 (pt) composições
DK2111555T3 (da) Diagnosticering af præeklampsi
DK2260873T3 (da) Pcylering af proteiner
DK3284820T3 (da) Fremgangsmåde til behandling af pyropheophytin-holdige sammensætninger
DK2408446T3 (da) Anvendelse af farmaceutiske sammensætninger, der indeholder mesembrenon
DK2393650T3 (da) Fremstilling af elastomerfilm
DK2506840T3 (da) Anvendelser af hæmmere af hypoksi-fremkaldende faktorer
BRPI1005318A2 (pt) composição
DK2501381T3 (da) Behandling af atrieflimmer
FR2948673B1 (fr) Compositions de resines pvc
BRPI1007245A2 (pt) composição polimérica